300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ireland
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Ecuador
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Europe (September 2026)

The most active venture capital funds investing in Europe Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Europe Biotech startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bpifrance
VC Fund
131 France, United States, Switzerland Seed, Series A Software, Information Technology, Health Care $757k–$34M
Sofinnova Partners
VC Fund
83 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $7M–$105M
HTGF (High-Tech Gruenderfonds)
VC Fund
82 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $850k–$31M
SOSV
VC Fund
80 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
UK Innovation & Science Seed Fund
VC Fund
68 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $482k–$14M
Parkwalk Advisors
VC Fund
66 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $991k–$45M
Scottish Enterprise
VC Fund
62 United Kingdom, United States, Switzerland Grant, Seed, Venture - Series Unknown Biotechnology, Software, Health Care $119k–$8.4M
Novo Holdings
VC Fund
57 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Future Planet Capital
VC Fund
54 United Kingdom, United States, Singapore Seed, Convertible Note Biotechnology, Health Care, Software $670k–$5.1M
Oxford Science Enterprises
VC Fund
53 United Kingdom, United States, Finland Seed, Series A, Series B Health Care, Biotechnology, Software $1.3M–$168M
SFC Capital
VC Fund
51 United Kingdom, United States, Canada Pre-Seed, Seed Artificial Intelligence, Software, Information Technology $126k–$2M
Enterprise Ireland
VC Fund
47 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $400k–$12M
Seventure Partners
VC Fund
45 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.2M–$63M
Kurma Partners
VC Fund
43 France, Switzerland, Spain Series A, Seed, Series B Health Care, Biotechnology, Medical $2.7M–$98M
Entrepreneurs First
VC Fund
40 United Kingdom, United States, India Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $54k–$41M
Scottish Investment Bank
VC Fund
39 United Kingdom, United States, France Venture - Series Unknown, Seed, Series A Software, Biotechnology, Health Care $244k–$7.5M
Boehringer Ingelheim Venture Fund
VC Fund
36 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Oxford Technology Management
VC Fund
36 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $33k–$8.5M
Inveready
VC Fund
35 Spain, United States, United Kingdom Seed, Series A Software, Biotechnology, Information Technology $400k–$14M
Centre for the Development of Industrial Technology (CDTI)
VC Fund
33 Spain, United States, France Grant, Seed Biotechnology, Health Care, Software $167k–$15M
O2h Ventures
VC Fund
33 United Kingdom, Hungary Seed, Venture - Series Unknown, Series A Biotechnology, Health Care, Pharmaceutical $603k–$25M
BioInnovation Institute
VC Fund
31 Denmark, Germany, Switzerland Convertible Note, Pre-Seed, Seed Biotechnology, Medical, Health Care $495k–$5.2M
Chalmers Ventures AB
VC Fund
29 Sweden Pre-Seed, Seed, Venture - Series Unknown Software, Biotechnology, Information Technology $5.8k–$3.5M
Forbion Capital Partners
VC Fund
29 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $16M–$180M
GO CAPITAL
VC Fund
29 France, Canada, Israel Seed, Venture - Series Unknown, Series A Software, Biotechnology, Health Care $549k–$13M
IP Group
VC Fund
29 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $456k–$30M
Almi Invest
VC Fund
28 Sweden, Norway, United States Venture - Series Unknown, Seed Software, Health Care, Information Technology $221k–$3.5M
Portugal Ventures
VC Fund
28 Portugal, United States, France Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, Artificial Intelligence $107k–$3.6M
Development Bank of Wales
VC Fund
27 United Kingdom, Australia, United States Seed, Debt Financing, Venture - Series Unknown Software, Health Care, Manufacturing $19k–$5.4M
Mercia Fund Managers
VC Fund
27 United Kingdom, United States, Hungary Seed, Venture - Series Unknown, Series A Software, Health Care, Biotechnology $250k–$14M
Meusinvest (Noshaq)
VC Fund
27 Belgium, France, Germany Series A, Seed, Venture - Series Unknown Biotechnology, Health Care, Medical $137k–$16M
European Investment Bank
VC Fund
27 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$587M
Catapult Ventures
VC Fund
27 United Kingdom, United States, Israel Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $150k–$5.6M
Epidarex Capital
VC Fund
27 United Kingdom, United States, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $551k–$48M
Business Growth Fund
VC Fund
26 United Kingdom, Ireland, United States Venture - Series Unknown, Private Equity, Series A Software, Information Technology, Manufacturing $3.4M–$27M
Karista
VC Fund
26 France, United States, Finland Seed, Series A, Series B Software, Biotechnology, Health Care $768k–$33M
Idinvest Partners
VC Fund
25 France, United States, Germany Series A, Series B, Venture - Series Unknown Software, Health Care, Biotechnology $3.9M–$66M
M Ventures
VC Fund
25 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Elaia
VC Fund
25 France, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $1.1M–$50M
Archangels
VC Fund
24 United Kingdom, United States Venture - Series Unknown, Seed Software, Health Care, Biotechnology $867k–$6.3M
Northstar Ventures
VC Fund
24 United Kingdom, United States, Indonesia Seed, Venture - Series Unknown, Series A Software, Health Care, Information Technology $43k–$10M
Syncona Partners LLP
VC Fund
24 United Kingdom, United States, Switzerland Series A, Series B, Seed Biotechnology, Medical, Health Care $1.9M–$156M
Omnes Capital
VC Fund
23 France, Germany, United States Series A, Series B Software, Biotechnology, Health Care $4.3M–$53M
Invivo Capital Partners
VC Fund
23 Spain, France, Belgium Seed, Series A Biotechnology, Pharmaceutical, Health Care $1.6M–$70M
Kelvin Capital
VC Fund
23 United Kingdom, United States Seed, Venture - Series Unknown Health Care, Biotechnology, Manufacturing $163k–$4.5M
PMV
VC Fund
23 Belgium, United States, The Netherlands Seed, Series A, Series B Software, Biotechnology, Health Care $1M–$43M
AdBio partners
VC Fund
22 France, Spain, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.2M–$37M
Oxford Capital
VC Fund
22 United Kingdom, United States, France Seed, Series A Software, Health Care, Biotechnology $1.7M–$16M
HealthCap
VC Fund
22 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Deepbridge Capital
VC Fund
22 United Kingdom, Spain, Australia Seed, Venture - Series Unknown, Series A Health Care, Biotechnology, Medical $142k–$15M
Access all 50 VC funds in Europe Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 131 investments in Europe Biotech startups

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 1680
  • Round size: Seed $757k–$6.1M; Series A $2.8M–$34M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $27M in 2025

Portfolio highlights

  • Nepsis — AI-powered software and debt advisory for renewable energy developers. Modern financing solutions for small & medium renewable projects.
  • Hiqute Diamond — High quality diamond plates for high-end applications
  • Tribun Health — Tribun Health provides a complete digital pathology platform for diagnosis, prognosis and biomarker analysis.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 83 investments in Europe Biotech startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 350
  • Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $755M in 2025

Portfolio highlights

  • Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 82 investments in Europe Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 739
  • Round size: Seed $850k–$7M; Series A $3.1M–$31M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Zimory — Founded in 2007, Zimory provides carrier-grade cloud infrastructure management software that allows service providers, enterprises and cloud brokers to fully leverage the power and elasticity of cloud computing. Zimory’s intelligent Cloud Suite simplifies, automates and expedites the creation, launch and management of all types of cloudenvironments – whether public, private, virtual private or hybrid. Zimory software is also a key enabler of cloud marketplaces for enterprise services, applications and infrastructure. Headquartered in Berlin, Zimory has development centers in Erfurt, Germany and Minsk, Belarus, a subsidiary office in New York City and is expanding its expertise and presence globally.
  • Alteva — Alteva develops battery cells for the decarbonisation of the global transport sector, and focus on high-energy density battery cells with high safety profiles specifically designed for the aviation and heavy-duty transport sectors.
  • Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 80 investments in Europe Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 68 investments in Europe Biotech startups

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 148
  • Round size: Seed $482k–$5.9M; Series A $2.9M–$14M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • KVector — KVector creates communication and sensing solutions with high gain and efficiency from X-band to sub-terahertz bands and beyond. Modern antenna systems are built by KVector.
  • Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
  • Singular Machines — Singular Machines is an engineering automation company that provides solutions to engineering issues.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 66 investments in Europe Biotech startups

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 325
  • Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $2.2M–$45M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 62 investments in Europe Biotech startups, 34 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 395
  • Round size: Seed $387k–$4.3M; Grant $119k–$4.2M; Venture - Series Unknown $726k–$8.4M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
  • QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
  • Singular Photonics — Singular Photonics is a startup that creates SPAD-based image sensors.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 57 investments in Europe Biotech startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 398
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 54 investments in Europe Biotech startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Singapore

Investor stats

  • Total investments: 281
  • Round size: Seed $670k–$5.1M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: Likely still investing — raised $23M in 2022

Portfolio highlights

  • Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
  • Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
  • K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 53 investments in Europe Biotech startups

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Finland

Investor stats

  • Total investments: 205
  • Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $299M in 2022

Portfolio highlights

  • MCatalysis — Manufacturing drop-in liquid commodities from distributed hydrocarbon feedstocks below commodity cost with small modular refining.
  • Caudal Energy — Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SFC Capital
VC Fund · London, England, United Kingdom · 51 investments in Europe Biotech startups, 56 in the past 12 months

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 754
  • Round size: Seed $126k–$2M; Pre-Seed $170k–$858k
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $1.9M in 2019

Portfolio highlights

  • Anemo Labs — We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with Machine Learning to characterize smells
  • FlairMakers — FlairMakers provides a digital talent platform connecting hospitality businesses with vetted freelance professionals.
  • Pure Capture Innovations — Pure Capture Innovations develop the next generation of sustainable adsorbents to solve the emerging PFAS crisis, removing 'forever chemicals' contaminating our water and affecting public health
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 47 investments in Europe Biotech startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 876
  • Round size: Seed $400k–$3.3M; Series A $2.2M–$12M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $1.2M in 2021

Portfolio highlights

  • Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
  • Adama Innovations — Sharp Conductive Single Crystal Diamond AFM Probes
  • Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 45 investments in Europe Biotech startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 265
  • Round size: Series A $3.2M–$28M; Series B $3.4M–$63M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
  • Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 43 investments in Europe Biotech startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Switzerland, Spain

Investor stats

  • Total investments: 145
  • Round size: Seed $2.7M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $236M in 2024

Portfolio highlights

  • EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Show all investments...

Entrepreneurs First
VC Fund · London, England, United Kingdom · 40 investments in Europe Biotech startups

We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 478
  • Round size: Seed $54k–$6.5M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely actively investing — fresh fund, raised $133M in 2026

Portfolio highlights

  • Sourcepulse — Your early warning system for software delivery (YC S23)
  • Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
  • HelmGuard AI — HelmGuard develops an AI-driven trust infrastructure platform for security, compliance, and third-party risk management. The company provides an operational risk infrastructure layer that centralizes fragmented security, compliance, and vendor data into a structured repository. Its platform coordinates autonomous, domain-specific AI agents thatperform continuous data indexing, compliance mapping, automated vendor assessments, and real-time security tracking. HelmGuard includes a risk operating system, a zero-knowledge verification engine for selective disclosure and cryptographic-style proofs, and persona-specific risk intelligence reporting. These capabilities support first-party, third-party, and customer-facing workflows across sectors such as financial services, SaaS, and healthcare. The platform is used by security, risk, and compliance teams to maintain continuous oversight of internal controls, vendor posture, and regulatory obligations while generating tailored, natural-language reports for business stakeholders.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 39 investments in Europe Biotech startups

Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 276
  • Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $244k–$4.1M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
  • Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 36 investments in Europe Biotech startups, 7 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 36 investments in Europe Biotech startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 111
  • Round size: Seed $33k–$2.2M; Series A $786k–$8.5M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
  • CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
  • Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Show all investments...

Inveready
VC Fund · Barcelona, Catalonia, Spain · 35 investments in Europe Biotech startups, 12 in the past 12 months

Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 266
  • Round size: Seed $400k–$4.7M; Series A $1.6M–$14M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $63M in 2024

Portfolio highlights

  • Inventia Kinetics — Inventia Kinetics specializes in the design, analysis, and manufacture of equipment and assembly tools for electronics sector.
  • Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Centre for the Development of Industrial Technology (CDTI)
VC Fund · Madrid, Madrid, Spain · 33 investments in Europe Biotech startups, 25 in the past 12 months

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Grant, Seed
  • Geography: Spain, United States, France

Investor stats

  • Total investments: 223
  • Round size: Seed $576k–$5.8M; Grant $167k–$15M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
  • FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
O2h Ventures
VC Fund · 33 investments in Europe Biotech startups

Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 60
  • Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

BioInnovation Institute
VC Fund · Copenhagen, Hovedstaden, Denmark · 31 investments in Europe Biotech startups

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Convertible Note, Pre-Seed, Seed
  • Geography: Denmark, Germany, Switzerland

Investor stats

  • Total investments: 92
  • Round size: Seed $532k–$1.8M; Pre-Seed $530k–$5.2M; Convertible Note $495k–$1.6M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • FimmCyte — FimmCyte is a Swiss biotech startup developing first in class treatment for endometriosis based on a novel differentially expressed target.
  • MATR Foods — MATR Foods is a food-tech startup that provides fungi-based food ingredients offering dishes produced from fungi like mushrooms, vegetables, and fruits.
  • Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
Show all investments...

Chalmers Ventures AB
VC Fund · Göteborg, Vastra Gotaland, Sweden · 29 investments in Europe Biotech startups

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Pre-Seed, Seed, Venture - Series Unknown
  • Geography: Sweden

Investor stats

  • Total investments: 280
  • Round size: Seed $274k–$2.3M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $357k–$3.5M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
  • InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 29 investments in Europe Biotech startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 222
  • Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$111M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fresh fund, raised $606M in 2026

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Solstice Oncology — Solstice Oncology is a clinical stage immuno-oncology company developing a therapeutic that meets cancer at its most vulnerable moment, before surgery, to drive deep pathological response and return patients to lasting health. The company's lead program is targeting colon cancer.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

GO CAPITAL
VC Fund · Rennes, Bretagne, France · 29 investments in Europe Biotech startups

GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: France, Canada, Israel

Investor stats

  • Total investments: 141
  • Round size: Seed $549k–$7.1M; Series A $2.1M–$13M; Venture - Series Unknown $723k–$9.5M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $25M in 2023

Portfolio highlights

  • Axomove — Axomove specializes in the prescription of video-based physical exercises. The company's movement knowledge is used by health professionals to improve remote monitoring of their patients and to avoid Musculoskeletal Disorders (MSDs) at work.
  • Olenbee — Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees.
  • NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 29 investments in Europe Biotech startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 214
  • Round size: Seed $456k–$8.5M; Series A $2.4M–$30M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely actively investing — fresh fund, raised $50M in 2026

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Show all investments...

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 28 investments in Europe Biotech startups

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Norway, United States

Investor stats

  • Total investments: 513
  • Round size: Seed $221k–$2.2M; Venture - Series Unknown $326k–$3.5M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $64M in 2024

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Qulsar — Qulsar provides high precision time synchronization solutions for 5G, private mobile, industrial IoT and real time data applications and infrastructures. Its solution combines Time Synchronization as a Service (TSaaS) and open and proprietary software running on off the shelf (COTS) hardware. Qulsar's solutions span multiple precision levelsand slashes cost of ownership and operation.
  • Boka konferens — Boka konferens provides an online booking platform that allows users to browse and book conference rooms and venue space for corporate offices. Their products serve consumers. For inquiries, their telephone number and email address are available on their website.
Show all investments...

Portugal Ventures
VC Fund · Porto, Lisboa, Portugal · 28 investments in Europe Biotech startups

Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme ParksMobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Portugal, United States, France

Investor stats

  • Total investments: 369
  • Round size: Seed $121k–$2M; Pre-Seed $107k–$796k; Venture - Series Unknown $121k–$3.6M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Aptoide — Find, discover and download the best apps and games for Android in the official Aptoide app store
  • Omniflow — Omniflow provides solutions powered by wind and solar for public spaces, Smart Lamppost, Smart Bench, Solar Smart Lighting, IoT Software, , Smart Pole, Smart City, Sustainability, CO2 reduction, decarbonization, Sustainable services
  • Codeplace — The best place to develop your coding skills with a comprehensive, specially curated list of tutorials and books.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 27 investments in Europe Biotech startups

Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Debt Financing, Venture - Series Unknown
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 288
  • Round size: Seed $327k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $350k–$5.4M
  • Lead/follow: 62% lead, 38% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
  • Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
  • Outlook Expeditions — Ready. For Life.
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 27 investments in Europe Biotech startups

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 144
  • Round size: Seed $250k–$2.1M; Series A $2M–$14M; Venture - Series Unknown $406k–$5.3M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
  • Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
  • MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 27 investments in Europe Biotech startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 82
  • Round size: Seed $137k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $2M–$16M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 27 investments in Europe Biotech startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 587
  • Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$370M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Skyborn Renewables — Skyborn Renewables develops, builds, and operates offshore wind projects across the full lifecycle. The company identifies sites, secures permits, structures financing, and manages engineering, procurement, and construction. Its teams plan grid connections and deliver operations and maintenance for utility-scale assets. Skyborn Renewables alsoprovides asset management, health and safety oversight, and environmental monitoring throughout project life. Services include offtake strategy and power sales support, stakeholder engagement, and supply chain coordination. The portfolio covers greenfield development, joint ventures, and acquisitions, with capabilities from early-stage studies to long-term operation. Technology work spans turbine selection, foundation design, cable layout, and digital performance analytics. Skyborn Renewables collaborates with partners to expand renewable generation and enable electrification through offshore wind energy.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 27 investments in Europe Biotech startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 105
  • Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 27 investments in Europe Biotech startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 51
  • Round size: Seed $551k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $145M in 2026

Portfolio highlights

  • Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
  • RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
  • Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Show all investments...

Business Growth Fund
VC Fund · London, England, United Kingdom · 26 investments in Europe Biotech startups

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Venture - Series Unknown, Private Equity, Series A
  • Geography: United Kingdom, Ireland, United States

Investor stats

  • Total investments: 561
  • Round size: Series A $4.1M–$21M; Private Equity $6.4M–$27M; Venture - Series Unknown $3.4M–$16M
  • Lead/follow: 86% lead, 14% follow
  • Last fund: Likely still investing — raised $97M in 2022

Portfolio highlights

  • Inoapps —
  • Flowline —
  • TMT ID — A leading provider of global mobile and device intelligence. We power leading identity providers, A2P SMS messaging companies and financial organisations.
Show all investments...

Karista
VC Fund · Paris, Ile-de-France, France · 26 investments in Europe Biotech startups

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Finland

Investor stats

  • Total investments: 159
  • Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — raised $44M in 2021

Portfolio highlights

  • AlephD — The programmatic performance company
  • Playtem — Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.
  • Plasmabiotics — PENTAX Medical PlasmaBiotics: Ultra-fast endoscope reprocessing solutions to improve patient safety and infection prevention.
Show all investments...

Idinvest Partners
VC Fund · Paris, Ile-de-France, France · 25 investments in Europe Biotech startups

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 338
  • Round size: Series A $3.9M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$65M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $97M in 2021

Portfolio highlights

  • Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
  • Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
  • StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 25 investments in Europe Biotech startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 187
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

Elaia
VC Fund · Paris, Ile-de-France, France · 25 investments in Europe Biotech startups

Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: France, United States, Spain

Investor stats

  • Total investments: 237
  • Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $154M in 2026

Portfolio highlights

  • Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
  • Ornikar — Ornikar is an online driving school that offers radically cheaper, uncomplicated and faster offer to obtain a driving license.Ornikar relies on a network of state-qualified teachers to offer an apprenticeship in mobile driving at reduced prices. The cmpany is an an online driving school more in tune with the demand of current and futuregenerations.The company's mission is to make the driver's license exam cheaper and its learning more enjoyable.
  • Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 24 investments in Europe Biotech startups

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 85
  • Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
  • Bioliberty — Engineering the future of physical and occupational therapy.
  • Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 24 investments in Europe Biotech startups, 6 in the past 12 months

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, United States, Indonesia

Investor stats

  • Total investments: 238
  • Round size: Seed $43k–$2M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $20M in 2024

Portfolio highlights

  • H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
  • Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
  • Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 24 investments in Europe Biotech startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 75
  • Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
  • Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Show all investments...

Omnes Capital
VC Fund · Paris, Ile-de-France, France · 23 investments in Europe Biotech startups

Omnes Capital takes a unique approach to renewable energy, transforming developers into independent power producers to provide green energy to millions.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Series B
  • Geography: France, Germany, United States

Investor stats

  • Total investments: 185
  • Round size: Series A $4.3M–$41M; Series B $4.4M–$53M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely actively investing — fresh fund, raised $132M in 2025

Portfolio highlights

  • SeqOne Genomics — Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGShas had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
  • Adictiz — Adictiz, a French company founded in 2009 by Charles Christory, develops and publishes social games for the web and mobile phones.With successful brands including “Space Dog” and “What a Stupid Pigeon”, which attract close to 2.5 million players every month, Adictiz has established itself as an expert player in social and mobile gaming.Basedat the EuraTechnologies economic excellence hub in Lille, which is dedicated to serving information and communication technology companies, Adictiz set up Adictiz Studio in late 2011, which specialises in the creation of customised social games for brands. Adictiz Studio was recently selected by Facebook as a PMD (Preferred Marketing Developer).
  • Complix — Complix is a biopharmaceutical company focused on the discovery and development of Alphabodiesâ„¢, a novel class of biopharmaceuticals that offer significant advantages over existing protein based therapies. Alphabodiesâ„¢ bind with high affinity to a wide range of disease targets and are particularly suited to address certain targets that aredifficult to reach with antibodies or other types of protein scaffolds. Due to their unique stability and versatility Alphabodiesâ„¢ can be delivered via alternative non-injectable routes of administration, unlike most therapeutic proteins.
Show all investments...

Invivo Capital Partners
VC Fund · Barcelona, Catalonia, Spain · 23 investments in Europe Biotech startups

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series A
  • Geography: Spain, France, Belgium

Investor stats

  • Total investments: 35
  • Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $44M in 2019

Portfolio highlights

  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Show all investments...

Kelvin Capital
VC Fund · Glasgow, Glasgow City, United Kingdom · 23 investments in Europe Biotech startups

Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Venture - Series Unknown
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 108
  • Round size: Seed $163k–$1.9M; Venture - Series Unknown $566k–$4.5M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kenoteq — Discover Kenoteq, pioneering the sustainable construction revolution with our innovative, ultra low-carbon building materials.
  • Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 23 investments in Europe Biotech startups, 8 in the past 12 months

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 159
  • Round size: Seed $1M–$4M; Series A $3M–$40M; Series B $6.6M–$43M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
  • Borro — Cashless deposit system
  • Storm — Storm is een producent van hernieuwbare energie. Samen met ons team ontwikkelen, bouwen en exploiteren we duurzame energieprojecten over het hele land: van wind- en zonneparken tot snellaadstations en batterijopslag. Dit telkens tegen een zo laag mogelijke maatschappelijke kost.
Show all investments...

AdBio partners
VC Fund · Paris, Ile-de-France, France · 22 investments in Europe Biotech startups

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 32
  • Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $116M in 2021

Portfolio highlights

  • Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 22 investments in Europe Biotech startups

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 160
  • Round size: Seed $1.7M–$3.9M; Series A $3.2M–$16M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $66M in 2015

Portfolio highlights

  • Flyttr — Flyttr is the leader in developing and deploying biosecurity countermeasures against critical pest threats that spread disease, threaten food security.
  • Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
  • Noggin HQ — The next generation of credit referencing is coming. Look busy.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 22 investments in Europe Biotech startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 22 investments in Europe Biotech startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Spain, Australia

Investor stats

  • Total investments: 91
  • Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — raised $1.4M in 2022

Portfolio highlights

  • upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
  • GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Europe Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists